Saturday 17 October 2026
Export NEOG’s income statement to Excel — free account
Neogen Corporation
NEOG Healthcare Medical Devices
Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025. In the quarter to August 2026, revenue grew 6.51%, EPS fell 132.1%, free cash flow grew 135.8% and total debt fell 2.31%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
11.81
0.46
−3.75%
Follow NEOG
| May '17 | May '18 | May '19 | May '20 | May '21 | May '22 | May '23 | May '24 | May '25 | May '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 6 | 5 | 5 | 4 | 6 | 3 | 5 | 3 | 5 |
P/E ratio |
55.52 | 62.44 | 49.01 | 63.58 | 79.34 | 58.80 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
27.87 | 42.83 | 32.80 | 33.57 | 39.25 | 18.41 | 1.89 | 1.75 | (0.28) | 1.11 |
P/S ratio |
6.70 | 9.77 | 7.06 | 9.03 | 10.37 | 5.41 | 4.02 | 3.08 | 1.38 | 2.23 |
Altman Z″-Score (non-manufacturers) |
14.59 | 16.41 | 18.08 | 17.12 | 17.34 | 14.78 | 3.41 | 3.46 | (0.23) | 2.06 |
P/FCF ratio |
52.52 | 80.71 | 59.46 | 61.06 | 89.35 | 65.34 | 0.00 | 0.00 | 0.00 | 60.63 |
Beneish M-Score |
(2.62) | (2.43) | (2.46) | (2.69) | (2.43) | (2.63) | (1.92) | (2.43) | (4.34) | (2.43) |
P/Operating CF |
159.08 | 172.42 | 140.08 | 147.31 | 221.15 | 139.74 | 36.32 | 106.30 | 75.25 | 64.24 |
P/B ratio |
5.09 | 6.94 | 4.58 | 5.21 | 5.78 | 3.21 | 1.05 | 0.91 | 0.60 | 0.93 |
Price to Tangible BV |
7.58 | 9.95 | 6.27 | 6.89 | 7.88 | 4.47 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
6.30 | 9.24 | 6.41 | 8.21 | 9.56 | 4.68 | 4.80 | 3.86 | 2.23 | 2.95 |
EV/EBITDA |
28.33 | 42.15 | 31.00 | 39.95 | 47.04 | 29.84 | 30.19 | 19.41 | 14.64 | 25.10 |
EV/Operating CF |
37.43 | 53.20 | 41.62 | 39.97 | 55.23 | 36.29 | 96.19 | 101.04 | 34.35 | 30.86 |
EV/FCF |
49.37 | 76.33 | 54.02 | 55.52 | 82.36 | 56.62 | (165.10) | (46.93) | (48.41) | 80.24 |
Quick Ratio |
5.89 | 7.49 | 9.15 | 8.83 | 8.82 | 6.18 | 2.74 | 2.23 | 1.62 | 2.10 |
Current Ratio |
8.14 | 9.71 | 11.75 | 11.08 | 11.03 | 8.05 | 4.03 | 3.82 | 3.32 | 3.82 |
Net Debt/EBITDA |
(1.80) | (2.42) | (3.12) | (3.99) | (3.99) | (4.59) | 4.92 | 3.92 | 5.60 | 5.95 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.13% | 0.11% | 0.10% | 19.51% | 19.58% | 25.96% | 23.72% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.28 | 0.28 | 0.43 | 0.38 |
Asset Turnover |
0.73 | 0.69 | 0.63 | 0.56 | 0.55 | 0.55 | 0.30 | 0.20 | 0.22 | 0.26 |
Operating CF/Net income |
1.38 | 1.09 | 1.06 | 1.44 | 1.33 | 1.41 | (1.79) | (3.76) | (0.05) | (10.53) |
Capex/Depreciation |
(0.99) | (1.23) | (0.83) | (1.31) | (1.27) | (1.01) | (0.70) | (0.89) | (0.08) | (0.41) |
Interest Coverage |
77.50 | 34.36 | 14.54 | 11.27 | 950.88 | 814.14 | 0.67 | 0.87 | (15.49) | (0.37) |
| 10.00% | 12.24% | 10.05% | 8.73% | 7.78% | 5.59% | (1.14%) | (0.30%) | (41.88%) | (0.38%) | |
| 8.95% | 11.02% | 9.16% | 7.97% | 7.09% | 5.05% | (0.82%) | (0.21%) | (27.33%) | (0.23%) | |
ROIC |
12.37% | 12.56% | 11.49% | 11.03% | 10.07% | 7.22% | 0.62% | 0.95% | (23.38%) | (0.50%) |
Return on Tangible Assets |
13.74% | 15.39% | 12.38% | 10.48% | 9.54% | 7.32% | (3.58%) | (1.32%) | (147.17%) | (1.02%) |
Average Days of Receivables |
69.86 | 72.54 | 72.78 | 73.91 | 71.54 | 69.01 | 68.01 | 68.33 | 62.58 | 61.56 |
Research and Development Expense of Revenue |
2.90% | 2.73% | 3.09% | 3.53% | 3.47% | 3.23% | 3.17% | 2.43% | 2.36% | 2.11% |
Selling, General and Administrative Expense of Revenue |
26.12% | 26.44% | 26.80% | 27.26% | 26.61% | 31.74% | 41.63% | 41.42% | 44.93% | 47.30% |
Intangible Assets out of Total Assets |
0.29 | 0.27 | 0.25 | 0.22 | 0.24 | 0.25 | 0.82 | 0.80 | 0.72 | 0.71 |
Share Based Compensation of Revenue |
1.47% | 1.23% | 1.34% | 1.55% | 1.37% | 1.36% | 1.24% | 1.49% | 1.93% | 1.54% |
Graham Net Nets |
0.10 | 0.08 | 0.13 | 0.12 | 0.11 | 0.18 | (0.25) | (0.29) | (0.64) | (0.33) |
Graham Number |
6.70 | 8.63 | 8.92 | 9.37 | 10.10 | 9.13 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
1.80% | 1.60% | 2.04% | 1.57% | 1.26% | 1.70% | (0.40%) | (0.33%) | (88.40%) | (0.34%) |
Free Cash Flow Yield |
1.90% | 1.24% | 1.68% | 1.64% | 1.12% | 1.53% | (0.72%) | (2.67%) | (3.35%) | 1.65% |
Revenue per Share |
3.54 | 3.87 | 3.99 | 3.98 | 4.40 | 4.90 | 4.35 | 4.27 | 4.12 | 4.00 |
Operating CF per Share |
0.60 | 0.67 | 0.62 | 0.82 | 0.76 | 0.63 | 0.22 | 0.16 | 0.27 | 0.38 |
Capex per Share |
(0.14) | (0.20) | (0.14) | (0.23) | (0.25) | (0.23) | (0.34) | (0.51) | (0.46) | (0.24) |
Free Cash Flow per Share |
0.45 | 0.47 | 0.47 | 0.59 | 0.51 | 0.41 | (0.13) | (0.35) | (0.19) | 0.15 |
Cash per Share |
1.42 | 2.05 | 2.58 | 3.27 | 3.58 | 3.54 | 1.30 | 0.79 | 0.59 | 0.85 |
Shareholders Equity per Share |
4.67 | 5.45 | 6.15 | 6.90 | 7.89 | 8.24 | 16.59 | 14.52 | 9.55 | 9.62 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4.67 | 5.45 | 6.15 | 6.90 | 7.89 | 8.24 | 16.59 | 14.52 | 9.55 | 9.62 |
Free Cash Flow |
45.70 | 48.19 | 49.18 | 61.83 | 54.38 | 43.61 | (23.90) | (76.00) | (41.30) | 32.00 |
Working Capital |
256.96 | 337.10 | 411.28 | 488.92 | 537.85 | 548.95 | 440.46 | 434.91 | 402.90 | 446.40 |
Capital Expenditures |
(14.58) | (20.95) | (14.66) | (24.05) | (26.71) | (24.43) | (64.93) | (111.30) | (99.50) | (51.20) |
Net Current Asset Value |
236.31 | 317.96 | 391.69 | 465.40 | 511.64 | 521.24 | (834.28) | (815.46) | (795.70) | (648.50) |
EV/EBIT |
34.74 | 52.40 | 39.02 | 50.84 | 60.38 | 42.12 | 105.20 | 60.87 | 0.00 | 0.00 |
Capex to Sales |
0.04 | 0.05 | 0.04 | 0.06 | 0.06 | 0.05 | 0.08 | 0.12 | 0.11 | 0.06 |
Price to Operating Income |
36.95 | 55.40 | 42.95 | 55.91 | 65.51 | 48.61 | 88.06 | 48.58 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.24 | 0.23 | 0.24 | 0.23 | 0.21 | 0.22 | 0.47 | 0.45 | 3.53 | 0.38 |
Cash ROIC |
7.43% | 6.25% | 5.43% | 5.78% | 4.45% | 3.44% | (0.56%) | (1.81%) | (1.33%) | 1.04% |
Accounts Receivable Turnover |
5.26 | 5.39 | 5.12 | 5.00 | 5.31 | 5.51 | 6.50 | 5.67 | 5.48 | 5.80 |
Accounts Payable Turnover |
11.82 | 11.44 | 11.17 | 9.93 | 10.23 | 9.71 | 7.49 | 5.76 | 5.82 | 5.82 |
Inventory Turnover |
2.75 | 2.84 | 2.74 | 2.45 | 2.59 | 2.55 | 3.25 | 2.85 | 2.49 | 2.76 |
Average Days of Payables |
31.31 | 35.78 | 31.30 | 42.19 | 34.43 | 44.46 | 67.19 | 65.86 | 61.39 | 62.51 |
Days of Inventory on Hand |
140.99 | 131.07 | 141.21 | 156.36 | 145.05 | 157.12 | 117.27 | 150.08 | 147.14 | 114.03 |
Average Receivables |
68.11 | 73.83 | 80.83 | 83.63 | 88.25 | 95.75 | 126.46 | 163.13 | 163.20 | 150.10 |
Average Payables |
16.02 | 18.50 | 19.91 | 22.36 | 24.78 | 29.26 | 55.64 | 79.87 | 81.33 | 79.35 |
Average Inventory |
68.76 | 74.57 | 81.00 | 90.52 | 97.88 | 111.51 | 128.06 | 161.54 | 190.03 | 167.55 |
Average Assets |
489.17 | 573.21 | 656.87 | 746.46 | 858.69 | 956.56 | 2,773.68 | 4,551.63 | 3,996.32 | 3,394.90 |
Average Common Equity |
437.96 | 515.97 | 599.04 | 681.54 | 782.78 | 863.88 | 2,010.80 | 3,139.18 | 2,607.67 | 2,082.05 |
Columns are period end dates · fundamentals updated 13 Oct 2026